Address: 9, bld Romain Rolland 75159 Paris Cedex 14,France
Tel: +33 (0)1 57 63 33 33
Web: http://www.sanofi.fr/l/fr/fr/index.jsp
Sanofi-Aventis provides therapeutic solutions that improve the health of everyone with our daily research, development and production of medicines and vaccines that address the major issues of health today and tomorrow.
With its approximately 40 locations throughout the territory, sanofi-aventis can help address the challenges of economic and human health in the regions. Premiere company in the pharmaceutical industry in France, sanofi-aventis is involved at every stage of the chain drug:
* On research and development (12 centers)
* In production (19 sites)
* In distribution (4 sites)
* Through our commercial and administrative (8 sites)
In France, sanofi-aventis spent 1.5 billion euros in research and development, representing 37% of R & D performed in France by the entire pharmaceutical industry (LEEM data).
Thrombosis
Cardiovascular
Metabolic Disorders
Oncology
Central Nervous System
Internal Medicine
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Aricept has been a very effective blockbuster for the group as a whole and the loss of exclusivity affects not only France but entire company. How is Eisai in France…
There is a lot of change occurring in the French pharmaceutical industry at the moment and this is no different for Boehringer Ingelheim. Just last September you moved into these…
As president of LEEM, what will be your legacy and what legacy would you like to instill in the organization? A legacy of re-industrialization in the French pharmaceutical and health…
Roche has a long history in France and currently enjoys a higher position than its worldwide ranking. Can you elaborate on the importance of this market for the group overall?…
Do you feel the industry has changed more over the past ten years than over the entire 40 years before? It’s an optical illusion. People always have had the feelings…
As the G5 brings together five very different companies – Ipsen, LFB, Pierre Fabre, Sanofi-Aventis, Servier – could you explain the origin behind the creation and the purpose of the…
You’ve been at the head of AstraZeneca France for 7 years through during which time there has been a lot of M&A activity in the industry as well as a…
July 2008 libre acèss (free access,) for OTC market was implemented – a measure where some selected OTC products were made available over the counter within the pharmacy. Could you…
FEFIS represents 11 different associations across the industry with a very broad scope. How does the organization represent all of these different sectors? FEFIS represents as much as possible activities…
After spending 15 years at the CEA (Nuclear Energy Center), you just accepted an offer to become the General Manager of INSERM at the very moment a political reform is…
Pharmaceuticals and Chemicals are inextricably linked industries which is evident through your board membership that is half comprised of chemical companies developing products for the pharmaceutical sector. To what degree…
France yet today you work for a foreign multinational within France. Can you speak to the differences in culture and what the transition has been like? I have spent half…
See our Cookie Privacy Policy Here
